Abstract:The clinical guidelines that underpin the use of drugs for mental disorders are informed by evidence from randomised controlled trials (RCTs). RCTs are performed to obtain marketing authorisation from regulators. The methods used in these RCTs could be appropriate for early phases of drug development because they identify drugs with important harms and drugs that are efficacious for specific health problems and populations. RCTs done before marketing authorisation do not tend to address clinical questions that concern the effectiveness of a drug in heterogeneous and comorbid populations, the optimisation of drug sequencing and discontinuation, or the comparative benefits and harms of different drugs that could be used for the same health problem. This Review proposes an overview of some shortcomings of RCTs, at an individual level and at the whole portfolio level, and identifies some methods in planning, conducting, and carrying out analyses in RCTs that could enhance their ability to support therapeutic decisions. These suggestions include: identifying patient-important questions to be investigated by psychopharmacological RCTs; embedding pragmatic RCTs within clinical practice to improve generalisability to target populations; collecting evidence about drugs in overlooked populations; developing methods to facilitate the recruitment of patients with mental disorders and to reduce the number of patients who drop out, using specific methods; using core outcome sets to standardise the assessment of benefits and harms; and recording systematically serious objective outcomes, such as suicide or hospitalisation, to be evaluated in meta-analyses. This work is a call to address questions relevant to patients using diverse design of RCTs, thus contributing to the development of a patient-centred, evidence-based psychiatry.

Characteristics and challenges of clinical outcome research

Outcomes Research: Science and Action

[Progress in methodological research on bridging the efficacy-effectiveness gap of clinical interventions (1): to improve the validity of real-world evidence]

Application of Pragmatic Clinical Trials in Clinical Evaluation of Chinese Medicine

Clinical Questions And Real Research

[Progress in methodological research on bridging the efficacy-effectiveness gap of clinical interventions(2): to improve the extrapolation of efficacy]

Clinical Studies with Traditional Chinese Medicine in the Past Decade and Future Research and Development

How to Perform Clinical Study of Acute Myeloid Leukemia

Investigation on Chinese clinicians’ perception of clinical trials

Quality over Quantity: a Necessary Path for Clinical Research Transformation in China

Review of current controversial issues in clinical trials

Designing clinically useful psychopharmacological trials: challenges and ways forward

Effectiveness studies: advantages and disadvantages

Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches.

Randomized clinical trial: gold standard of experimental designs - importance, advantages, disadvantages and prejudices

Conducting Real-world Evidence Studies on the Clinical Outcomes of Diabetes Treatments

Strengthening causal inference from randomised controlled trials of complex interventions

Clinical Research Methods for Treatment, Diagnosis, Prognosis, Etiology, Screening, and Prevention: A Narrative Review.

Traditional Chinese Medicine: An Update on Clinical Evidence

Methods for Neuroscience Drug Development: Guidance on Standardization of the Process for Defining Clinical Outcome Strategies in Clinical Trials

The cornerstones of randomized clinical trials